ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,514.90
1.16%
S&P ASX All Technology
4,008.60
0.23%
Brent Oil
74.555
-0.03%
US Dollar vs AUD
1.59636
0.32%
Bitcoin
97,693.84
1.11%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Vivoryon Therapeutics Nv (0R3M) Share Price

Vivoryon Therapeutics Nv

Vivoryon Therapeutics Nv (0R3M)

LSE
4.71
0.00
(0.00%)
Closed 06 February 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
4.71
Bid
0.00
Offer
0.00
Volume
32
0.00 Day's Range 0.00
4.71 52 Week Range 4.71
Market Cap
-
Previous Close
4.71
Open
-
Last Trade
18
@
1.946
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
3,734
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
-3.62M
Net Profit
-28.34M

About Vivoryon Therapeutics Nv

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.vivoryon.com
Headquarters
Halle, Deu
Founded
-
Vivoryon Therapeutics Nv is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker 0R3M. The last closing price for Vivoryon Therapeutics Nv was 4.71 €. Over the last year, Vivoryon Therapeutics Nv shares have traded in a share price range of 4.71 € to 4.71 €.

Vivoryon Therapeutics Nv currently has 0 shares in issue.

Ask ADVFN Intelligence (AI)

0R3M Latest News

More News

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function

Vivoryon Therapeutics N.V. Presents Topline Phase 2 Data from VIVA-MIND Strongly Supporting Varoglutamstat’s Potential to Improve Kidney Function Vivoryon Therapeutics N.V. Presents Topline Phase...

09 December 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024

Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress on December 10, 2024 Vivoryon Therapeutics N.V. to Report Q3 2024 Financial Results and Operational Progress...

04 December 2024
UK Regulatory

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024

Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of...

26 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024

Vivoryon Therapeutics N.V. Announces Late-breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 Halle (Saale) / Munich, Germany, October 11, 2024 – Vivoryon...

12 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event

Vivoryon Therapeutics N.V. Shares Highlights from Virtual Kidney Disease KOL Event Halle (Saale) / Munich, Germany, October 1, 2024 – Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY;...

01 October 2024
UK Regulatory

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease

Vivoryon Therapeutics N.V. Reports H1 2024 Progress Marked by Compelling Kidney Function Data and Execution of Strategy to Advance Varoglutamstat in Kidney Disease Vivoryon Therapeutics N.V...

12 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association

Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and Change to Articles of Association Vivoryon Therapeutics N.V. Announces Completion of Share Capital Reduction and...

06 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024

Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial Results on September 12, and to Host KOL Event on September 30, 2024 Vivoryon Therapeutics N.V. to Report Half Year 2024 Financial...

05 September 2024
UK Regulatory

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in Diabetic Kidney Disease

Vivoryon Therapeutics N.V. Announces New Data Showing Unique Treatment Effects of Varoglutamstat on Kidney Function in Patients with Diabetes and Outlines Proposed Clinical Development Plan in...

18 July 2024
UK Regulatory

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease

Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on Progress in Kidney Disease Vivoryon Therapeutics N.V. to Host R&D Update Call on July 18, 2024 Focused on...

09 July 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1004.714.714.711224.71DE
4004.714.714.715364.71DE
12004.714.714.7137344.71DE
26004.714.714.7139334.71DE
52004.714.714.71121794.71DE
156004.714.714.7159754.71DE
260004.714.714.7142164.71DE

0R3M - Frequently Asked Questions (FAQ)

What is the current Vivoryon Therapeutics Nv share price?
The current share price of Vivoryon Therapeutics Nv is 4.71 €
What is the 1 year trading range for Vivoryon Therapeutics Nv share price?
Vivoryon Therapeutics Nv has traded in the range of 4.71 € to 4.71 € during the past year
What is the reporting currency for Vivoryon Therapeutics Nv?
Vivoryon Therapeutics Nv reports financial results in EUR
What is the latest annual turnover for Vivoryon Therapeutics Nv?
The latest annual turnover of Vivoryon Therapeutics Nv is EUR -3.62M
What is the latest annual profit for Vivoryon Therapeutics Nv?
The latest annual profit of Vivoryon Therapeutics Nv is EUR -28.34M
What is the registered address of Vivoryon Therapeutics Nv?
The registered address for Vivoryon Therapeutics Nv is WEINBERGWEG 22, HALLE, 06120
What is the Vivoryon Therapeutics Nv website address?
The website address for Vivoryon Therapeutics Nv is www.vivoryon.com
Which industry sector does Vivoryon Therapeutics Nv operate in?
Vivoryon Therapeutics Nv operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GFINGfinity Plc
0.095p
(72.73%)
576.77M
XSGXeros Technology Group Plc
0.70p
(33.33%)
23.5M
OMIOrosur Mining Inc
9.55p
(29.93%)
11.76M
SNGSynairgen Plc
2.49p
(27.86%)
229.83k
IKAIlika Plc
34.25p
(26.85%)
1.91M
WBIWoodbois Limited
0.0525p
(-36.36%)
546.31M
CRVCraven House Capital Plc
US$ 0.275
(-26.67%)
49.99k
KRPZKropz Plc
0.85p
(-26.09%)
432.89k
MACMarechale Capital Plc
2.35p
(-24.19%)
26.92M
TRCThe Revel Collective Plc
0.175p
(-22.22%)
5.52M
NTVONativo Resources Plc
0.0017p
(0.00%)
2.07B
GFINGfinity Plc
0.095p
(72.73%)
576.77M
WBIWoodbois Limited
0.0525p
(-36.36%)
546.31M
OBDOxford Biodynamics Plc
0.55p
(10.00%)
373.53M
MSMNMosman Oil And Gas Limited
0.04p
(-8.05%)
338.97M

Discussion

View Full Feed
bigbux1 bigbux1 2 minutes ago
Scroll 9 down...https://dilutiontracker.com/app/reverse-split
WINT
MasterBlastr MasterBlastr 3 minutes ago
If anything it would be the opposite.
DJT
blownaccount9 blownaccount9 3 minutes ago
I was just hoping he was throwing support behind the idea to seem “on board” with priorities for the entire administration.
FNMA
janice shell janice shell 4 minutes ago
https://x.com/BrettBruen/status/1887229284340932886
4gh1rx 4gh1rx 4 minutes ago
Whales eyeing $AXXA$

$AXXA
______________

What do you get when you add:

$60.4 million in revenues + $30.4 million in gross profits + $70 million in projected 2025 revs + $153 million in assets +audits (2019) + $20 million debt r
AXXA
ranchhand71 ranchhand71 5 minutes ago
IMHO Much too pessimistic-not very unique view.
Here is better more experienced view:
https://www.barchart.com/story/news/30402823/legendary-investor-bill-ackman-likes-these-2-stocks-should-you
SOFI
boston745 boston745 5 minutes ago
This is something every Tesla owner that can afford it needs to have done if their Tesla suffers spontaneous fracturing of suspension components. Have Spectral Analysis done to see if there is an increase in impurities around the fracture points. If there is then its highly likely that the Hutchison
TSLA
Juststoppingby Juststoppingby 8 minutes ago
After the deliberation of the Corporate Review Committee, the Korea Exchange has granted an improvement period until April 17, 2025, and we would like to inform you that the suspension of trading of the company's issued shares will continue during the improvement period.
https://investorshub.
CRTG
jcromeenes jcromeenes 8 minutes ago
We all know he'll have a hit piece out tomorrow. He always does.
FNMA
DungSpawter DungSpawter 9 minutes ago
The ignorant bashers post straw man arguments and have barely enough intellectual firepower to cut and paste the same tired posts hour after hour, day after day, year after year. If brains were dynamite, you couldn’t even blow your nose.
VPLM
dinogreeves dinogreeves 9 minutes ago
Momentum is on our side. This is a beast getting to roar. When this goes and the time when they audit report comes out and no altercation with the numbers, you haven't seen nothing yet, this will go so hard and fast, nothing will be able to stop it. This is exact the same setup as $CVNA (Thank yo
CVNA
Preciouslife1 Preciouslife1 10 minutes ago
https://www.cbssports.com/mlb/news/pete-alonso-re-signs-with-mets-all-star-slugger-agrees-to-two-year-54-million-deal-per-report/
Panzer Panzer 12 minutes ago
Yes, at multiple pennies or more 
RITE
mutant mutant 13 minutes ago
Dear friends on the uwbkq board. Question, fiction: perhaps someone [ King Arthur or Prince Valiant ] got cold feet/ cold footed. Is there any chance the “an endowment” = “stendec needed more money [ or more oxygen, or added a third team person ]’ .’[ stendec ] gift wrapping never says: ah chew. It
TightCoil TightCoil 15 minutes ago
FNMA CLOSED @ $5.98
FMCC CLOSED @ $5.39
Look closely at those prices
Now (for FNMA) visualize the figure, $5..98, as floating in space,
a wayward, wandering figure in the vastness of outer space, now
visualize a solar wind coming up from below the floating $5.98,
FMCC
janice shell janice shell 15 minutes ago
I wonder how many of the SS agents would actually take a bullet for orange boy?

I think usually any president's SS details are composed of agents who like him and approve of him. Of course I suppose that could change in extraordinary circumstances.
dinogreeves dinogreeves 18 minutes ago
Daughter as at a double now. This will hit the teens within 6 months, if they execute on their plans. The only pure play AI in the military sector.
OSS
ReasearchThis ReasearchThis 19 minutes ago
$45÷0.10 = 450.00 days to $50+ consider uplist, 1 to 3 Plus...
Any thoughts
TCNNF
dinogreeves dinogreeves 19 minutes ago
Been going to CAVA Porter Ranch, every week. So busy, it will knock you off your socks, definitely not as busy as Porto's printing money, but easy 60-75 thousand dollars a day. Great investment if you can hold at least 5-8 years, easily 4 digits.
CAVA
BDEZ BDEZ 20 minutes ago
The censors are now the ones getting demonetized. Oh the irony.

https://x.com/elonmusk/status/1887037252984860679
sissyjane1 sissyjane1 20 minutes ago
0000000000000000000000000000000000000000000000 volume
BNCM
Stock_Barber Stock_Barber 21 minutes ago
I also can't convince my dog that the Earth is larger than the block we live on!

🤣
DBMM
konshe konshe 21 minutes ago
[[[--George Sharp - Advocate for truth in the OTC
@GeorgeASharp
If $RDGL was trading on the Nasdaq, I believe that it would be trading at 200x it's current price and volume. This is just plain exciting. (This is not a recommendation buy or sell RDGL)--]]

WOW, 200 x 0.13=
RDGL
norisknorewards norisknorewards 21 minutes ago
Only thing I remember is you clowning my bullish posts, ya day trader
NWBO

Your Recent History

LSE
0R3M
Vivoryon Therapeutics Nv
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads